Apollon and an MIT lab today shared clinical findings demonstrating the accuracy of their non-invasive continuous glucose monitor (CGM) device. Boston-based Apollon and MIT’s Laser Biomedical Research Center (LBRC) published their findings from the peer-reviewed clinical study in the Journal of Diabetes Science and Technology. Outcomes demonstrated that a compact, non-invasive CGM device based on band-pass […]
